Methods of using (1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid
Patent
·
OSTI ID:1171656
(1S,3S)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid also known as CPP-115 or its pharmaceutically acceptable salts can be used to treat addiction and neurological disorders such as epilepsy without side effects such as visual field defects caused by vigabatrin (Sabril).
- Research Organization:
- Brookhaven National Laboratory (BNL), Upton, NY (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC02-98CH10886
- Assignee:
- Catalyst Pharmaceutical Partners (Coral Gables, FL)
- Patent Number(s):
- 8,969,413
- Application Number:
- 13/581,187
- OSTI ID:
- 1171656
- Country of Publication:
- United States
- Language:
- English
Similar Records
Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1 S ,3 S )-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115)
Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1S ,3S)-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115)
Design and Mechanism of Tetrahydrothiophene-Based γ-Aminobutyric Acid Aminotransferase Inactivators
Journal Article
·
Mon Feb 09 23:00:00 EST 2015
· Journal of the American Chemical Society
·
OSTI ID:1392007
Mechanism of Inactivation of γ-Aminobutyric Acid Aminotransferase by (1S ,3S)-3-Amino-4-difluoromethylene-1-cyclopentanoic Acid (CPP-115)
Journal Article
·
Thu Jan 22 19:00:00 EST 2015
· Journal of the American Chemical Society
·
OSTI ID:1261139
Design and Mechanism of Tetrahydrothiophene-Based γ-Aminobutyric Acid Aminotransferase Inactivators
Journal Article
·
Wed Mar 25 00:00:00 EDT 2015
· Journal of the American Chemical Society
·
OSTI ID:1391869